Investigation of xenotropic murine leukemia virus-related virus (XMRV) in human and other cell lines

Biologicals

Volumn 39, Issue 6, 2011, Pages 378-383

  Williams, Dhanya K ^a   Galvin, Teresa A ^a   Ma, Hailun ^a   Khan, Arifa S ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Cell lines; Polymerase chain reaction (PCR) assay; Vaccines; Xenotropic murine leukemia virus related virus (XMRV)

Indexed keywords

DNA; DNA FRAGMENT; VIRUS DNA;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN; CELL STRAIN A549; CELL STRAIN HEK293; CELL STRAIN MRC 5; CONTROLLED STUDY; ENVELOPE GENE; EXPOSURE; GENE AMPLIFICATION; GENE SEQUENCE; GROUP SPECIFIC ANTIGEN GENE; HELA CELL; HUMAN; HUMAN CELL; INFECTION RISK; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VERO CELL; VIRAL CONTAMINATION; VIRUS GENE; VIRUS INFECTION; XENOTROPIC MULV RELATED VIRUS;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; DNA PRIMERS; DRUG CONTAMINATION; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; HEK293 CELLS; HELA CELLS; HUMANS; MICE; POLYMERASE CHAIN REACTION; RETROVIRIDAE INFECTIONS; VERO CELLS; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

MURINE LEUKEMIA VIRUS; XENOTROPIC MURINE LEUKEMIA VIRUS;

EID: 80055051291     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2011.08.011     Document Type: Article

References (50)

1. Merten O.W. Virus contaminations of cell cultures - A biotechnological view. Cytotechnology 2002, 39(2):91-116.
2. Petricciani J.C. An overview of viral and viral-like agents in cell culture systems. Cytotechnology 1998, 28(1-3):49-52.
3. Stang A., Petrasch-Parwez E., Brandt S., Dermietzel R., Meyer H.E., Stuhler K., et al. Unintended spread of a biosafety level 2 recombinant retrovirus. Retrovirology 2009, 6:86.
4. Raisch K.P., Pizzato M., Sun H.Y., Takeuchi Y., Cashdollar L.W., Grossberg S.E. Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75. Virology 2003, 308(1):83-91.
5. Takeuchi Y., McClure M.O., Pizzato M. Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. J Virol 2008, 82(24):12585-12588.
6. U.S. Food And Drug Administration. May 14, 2010. http://wwwfdagov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm212140htm.
7. Pastoret P.P. Human and animal vaccine contaminations. Biologicals 2010, 38(3):332-334.
8. Wessman S.J., Levings R.L. Collective experiences of adventitious viruses of animal-derived raw materials and what can be done about them. Cytotechnology 1998, 28(1-3):43-48.
9. Khan A.S. Regulatory considerations for raw materials used in biological products. PDA J Pharm Sci Technol 2010, 64(5):451-457.
10. U.S. Food and Drug Administration. May 7, 2010. http://wwwfdagov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/BloodVaccinesandOtherBiologics/VaccinesandRelatedBiologicalProductsAdvisoryCommittee/UCM215266pdf.
11. Baylis S.A., Finsterbusch T., Bannert N., Blumel J., Mankertz A. Analysis of porcine circovirus type 1 detected in rotarix vaccine. Vaccine 2011, 29(4):690-697.
12. Rubino M.J. Raw materials case histories. PDA J Pharm Sci Technol 2010, 64(5):440-441.
13. Kerr A., Nims R. Adventitious viruses detected in biopharmaceutical Bulk harvest samples over a 10 year period. PDA J Pharm Sci Technol 2010, 64(5):481-485.
14. Khan A.S. Characterization and qualification of cell substrates for manufacturing viral vaccines in the United States. BioProcessing 2009, 8(3):8-12.
15. Khan A.S. Testing considerations for novel cell substrates: a regulatory perspective. PDA J Pharm Sci Technol 2010, 64(5):426-431.
16. Guidance for industry: Characterization and qualification of cell substrates and other biological materials used in the production of viral vaccines for infectious disease indications 2010, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD. http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/UCM202439.pdf.
17. Brown P.O. Integration. Retroviruses 1997, 161-203. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. J. Coffin, S.H. Hughes, H. Varmus (Eds.).
18. Urisman A., Molinaro R.J., Fischer N., Plummer S.J., Casey G., Klein E.A., et al. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006, 2(3):e25.
19. Lombardi V.C., Ruscetti F.W., Das Gupta J., Pfost M.A., Hagen K.S., Peterson D.L., et al. Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 2009, 326(5952):585-589.
20. Erlwein O., Robinson M.J., Kaye S., Wills G., Izui S., Wessely S., et al. Investigation into the presence of and serological response to XMRV in CFS patients. PLoS One 2011, 6(3):e17592.
21. Groom H.C., Boucherit V.C., Makinson K., Randal E., Baptista S., Hagan S., et al. Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 2010, 7:10.
22. Henrich T.J., Li J.Z., Felsenstein D., Kotton C.N., Plenge R.M., Pereyra F., et al. Xenotropic murine leukemia virus-related virus prevalence in patients with chronic fatigue syndrome or chronic immunomodulatory conditions. J Infect Dis 2010, 202(10):1478-1481.
23. Hong P., Li J., Li Y. Failure to detect xenotropic murine leukaemia virus-related virus in Chinese patients with chronic fatigue syndrome. Virol J 2010, 7:224.
24. Satterfield B.C., Garcia R.A., Jia H., Tang S., Zheng H., Switzer W.M. Serologic and PCR testing of persons with chronic fatigue syndrome in the United States shows no association with xenotropic or polytropic murine leukemia virus-related viruses. Retrovirology 2011, 8:12.
25. Switzer W.M., Jia H., Hohn O., Zheng H., Tang S., Shankar A., et al. Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology 2010, 7:57.
26. van Kuppeveld F.J., de Jong A.S., Lanke K.H., Verhaegh G.W., Melchers W.J., Swanink C.M., et al. Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort. BMJ 2010, 340:c1018.
27. Sakuma T., Hue S., Squillace K.A., Tonne J.M., Blackburn P.R., Ohmine S., et al. No evidence of XMRV in prostate cancer cohorts in the midwestern United States. Retrovirology 2011, 8:23.
28. Furuta R.A., Miyazawa T., Sugiyama T., Kuratsune H., Ikeda Y., Sato E., et al. No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan. Retrovirology 2011, 8:20.
29. Garson J.A., Kellam P., Towers G.J. Analysis of XMRV integration sites from human prostate cancer tissues suggests PCR contamination rather than genuine human infection. Retrovirology 2011, 8:13.
30. Menendez-Arias L. Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome. Rev Med Virol 2011, 21(1):3-17.
31. Hohn O., Krause H., Barbarotto P., Niederstadt L., Beimforde N., Denner J., et al. Lack of evidence for xenotropic murine leukemia virus-related virus(XMRV) in German prostate cancer patients. Retrovirology 2009, 6:92.
32. Stoye J.P., Silverman R.H., Boucher C.A., Le Grice S.F. The xenotropic murine leukemia virus-related retrovirus debate continues at first international workshop. Retrovirology 2010, 7:113.
33. Lo S.C., Pripuzova N., Li B., Komaroff A.L., Hung G.C., Wang R., et al. Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci U S A 2010, 107(36):15874-15879.
34. Coffin J.M. Endogenous viruses. RNA tumor viruses 1984, 1109-1203. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. 2nd ed. R. Weiss, N. Teich, H. Varmus, J. Coffin (Eds.).
35. Shin C.H., Bateman L., Schlaberg R., Bunker A.M., Leonard C.J., Hughen R.W., et al. Absence of XMRV and other MLV-related viruses in patients with chronic fatigue syndrome. J Virol 2011.
36. Switzer W.M., Jia H., Zheng H., Tang S., Heneine W. No association of xenotropic murine leukemia virus-related viruses with prostate cancer. PLoS One 2011, 6(5):e19065.
37. Hue S., Gray E.R., Gall A., Katzourakis A., Tan C.P., Houldcroft C.J., et al. Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 2010, 7(1):111.
38. Kaiser J. Chronic fatigue syndrome. Studies point to possible contamination in XMRV findings. Science 2011, 331(6013):17.
39. Oakes B., Tai A.K., Cingoz O., Henefield M.H., Levine S., Coffin J.M., et al. Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences. Retrovirology 2010, 7:109.
40. Smith R.A. Contamination of clinical specimens with MLV-encoding nucleic acids: implications for XMRV and other candidate human retroviruses. Retrovirology 2010, 7:112.
41. Sato E., Furuta R.A., Miyazawa T. An endogenous murine leukemia viral genome contaminant in a commercial RT-PCR kit is amplified using standard primers for XMRV. Retrovirology 2010, 7:110.
42. Robinson M.J., Erlwein O.W., Kaye S., Weber J., Cingoz O., Patel A., et al. Mouse DNA contamination in human tissue tested for XMRV. Retrovirology 2010, 7:108.
43. Sramkoski R.M., Pretlow T.G., Giaconia J.M., Pretlow T.P., Schwartz S., Sy M.S., et al. A new human prostate carcinoma cell line, 22Rv1. In Vitro Cell Dev Biol Anim 1999, 35(7):403-409.
44. Retrovirology Cohen J. More negative data for link between mouse virus and human disease. Science 2011, 331(6022):1253-1254.
45. Knouf E.C., Metzger M.J., Mitchell P.S., Arroyo J.D., Chevillet J.R., Tewari M., et al. Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J Virol 2009, 83(14):7353-7356.
46. Yan Y., Liu Q., Kozak C.A. Six host range variants of the xenotropic/polytropic gammaretroviruses define determinants for entry in the XPR1 cell surface receptor. Retrovirology 2009, 6:87.
47. Stieler K., Schulz C., Lavanya M., Aepfelbacher M., Stocking C., Fischer N. Host range and cellular tropism of the human exogenous gammaretrovirus XMRV. Virology 2010, 399(1):23-30.
48. Chaipan C., Dilley K.A., Paprotka T., Delviks-Frankenberry K.A., Venkatachari N.J., Hu W.S., et al. Severe restriction of xenotropic murine leukemia virus-related virus replication and spread in cultured human peripheral blood mononuclear cells. J Virol 2011.
49. Steffen D., Weinberg R.A. The integrated genome of murine leukemia virus. Cell 1978, 15(3):1003-1010.
50. Gregory TR. Animal genome size database. 2005. http://www.genomesize.com.